143 related articles for article (PubMed ID: 22221052)
21. Design and Implementation of High-Throughput Screening Assays.
Powell DJ; Hertzberg RP; Macarrόn R
Methods Mol Biol; 2016; 1439():1-32. PubMed ID: 27316985
[TBL] [Abstract][Full Text] [Related]
22. tcpl: the ToxCast pipeline for high-throughput screening data.
Filer DL; Kothiya P; Setzer RW; Judson RS; Martin MT
Bioinformatics; 2017 Feb; 33(4):618-620. PubMed ID: 27797781
[TBL] [Abstract][Full Text] [Related]
23. A robust high-throughput sandwich cell-based drug screening platform.
Zhang S; Tong W; Zheng B; Susanto TA; Xia L; Zhang C; Ananthanarayanan A; Tuo X; Sakban RB; Jia R; Iliescu C; Chai KH; McMillian M; Shen S; Leo H; Yu H
Biomaterials; 2011 Feb; 32(4):1229-41. PubMed ID: 20971505
[TBL] [Abstract][Full Text] [Related]
24. Biomarker discovery using dry-lab technologies and high-throughput screening.
Chang HT
Biomark Med; 2016 Jun; 10(6):559-61. PubMed ID: 27278686
[No Abstract] [Full Text] [Related]
25. Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems.
Patel NR; Aryasomayajula B; Abouzeid AH; Torchilin VP
Ther Deliv; 2015; 6(4):509-20. PubMed ID: 25996047
[TBL] [Abstract][Full Text] [Related]
26. Re: Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening.
Assimos DG
J Urol; 2015 Oct; 194(4):1015. PubMed ID: 26382786
[No Abstract] [Full Text] [Related]
27. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
Beresini MH; Liu Y; Dawes TD; Clark KR; Orren L; Schmidt S; Turincio R; Jones SW; Rodriguez RA; Thana P; Hascall D; Gross DP; Skelton NJ
J Biomol Screen; 2014 Jun; 19(5):758-70. PubMed ID: 24518067
[TBL] [Abstract][Full Text] [Related]
28. [Screening methods for ion-channels drug discovery and new ideas].
Fujii M; Ohya S; Yamamura H; Imaizumi Y
Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):229-33. PubMed ID: 22156258
[No Abstract] [Full Text] [Related]
29. Rethinking molecular similarity: comparing compounds on the basis of biological activity.
Petrone PM; Simms B; Nigsch F; Lounkine E; Kutchukian P; Cornett A; Deng Z; Davies JW; Jenkins JL; Glick M
ACS Chem Biol; 2012 Aug; 7(8):1399-409. PubMed ID: 22594495
[TBL] [Abstract][Full Text] [Related]
30. High-throughput analysis of behavior for drug discovery.
Alexandrov V; Brunner D; Hanania T; Leahy E
Eur J Pharmacol; 2015 Mar; 750():82-9. PubMed ID: 25592319
[TBL] [Abstract][Full Text] [Related]
31. Integrative system biology strategies for disease biomarker discovery.
Zhang H; Hu H; Deng C; Chun Y; Zhou S; Huang F; Zhou Q
Comb Chem High Throughput Screen; 2012 May; 15(4):286-98. PubMed ID: 22221061
[TBL] [Abstract][Full Text] [Related]
32. Development of a novel multi-layer microfluidic device towards characterization of drug metabolism and cytotoxicity for drug screening.
Wu Q; Gao D; Wei J; Jin F; Xie W; Jiang Y; Liu H
Chem Commun (Camb); 2014 Mar; 50(21):2762-4. PubMed ID: 24481240
[TBL] [Abstract][Full Text] [Related]
33. Computational proteomics: designing a comprehensive analytical strategy.
Goh WW; Wong L
Drug Discov Today; 2014 Mar; 19(3):266-74. PubMed ID: 23872277
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening.
Subedi A; Shimizu T; Ryo A; Sanada E; Watanabe N; Osada H
Biochem Biophys Res Commun; 2016 Jun; 474(3):528-533. PubMed ID: 27120460
[TBL] [Abstract][Full Text] [Related]
35. A high-throughput screen to identify novel calcineurin inhibitors.
Margassery LM; Kennedy J; O'Gara F; Dobson AD; Morrissey JP
J Microbiol Methods; 2012 Jan; 88(1):63-6. PubMed ID: 22056231
[TBL] [Abstract][Full Text] [Related]
36. Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay.
Toots M; Ustav M; Männik A; Mumm K; Tämm K; Tamm T; Ustav E; Ustav M
PLoS Pathog; 2017 Feb; 13(2):e1006168. PubMed ID: 28182794
[TBL] [Abstract][Full Text] [Related]
37. High content screening: seeing is believing.
Zanella F; Lorens JB; Link W
Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
[TBL] [Abstract][Full Text] [Related]
38. Microfluidics: Analog-to-digital drug screening.
Wootton RC; Demello AJ
Nature; 2012 Feb; 483(7387):43-4. PubMed ID: 22382977
[No Abstract] [Full Text] [Related]
39. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
40. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
Zhang X; Wong SE; Lightstone FC
J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
